FREMONT, CA: Most of the citizens in the United States have been diagnosed, with cardiovascular disease (CVD). 121.5 million U.S. adults suffer this disease, involving hypertension as its predominant symptom. It is termed as 'silent killer' by doctors as it does not show any sign until it's too late. The first leading cause of death in the U.S. is heart disease, while heart stroke stands in the fifth position.
Researchers are now trying to study if there is a blood test that could accurately predict whether a person will have heart disease or a stroke. This kind of test already exists, as the research suggests. Scientists may be able to prognosticate a person's risk of eventually developing CVD by detecting the blood levels of specific proteins that heart muscles release when they are injured.
The scientists recognized the fluctuations in troponin levels in 85% of the participants and applied Cox proportional hazards models to examine the links within these levels and cardiovascular disease. Research shows that high levels of troponin correlated strongly with increased global CVD incidence in the general population independent of traditional danger circumstances. An accurate way of predicting CVD risk is the high-sensitivity troponin tests. Dr. Ballantyne, during the research, said that they are trying to find out if these tests can be used, in the general population. This is to give information as to who is most likely to have a future problem, be it a stroke, heart attack, or heart failure. He also added that if the first time a person finds out that they are at risk for heart failure, they start getting short of breath and end up in a hospital.
Knowing the risks in advance can help people to take preventive measures. Real-time checks on the blood pressure and other such clinical precautions help in mitigating health threats in the long run. Though doctors use troponin tests to diagnose a heart attack, they do not accept them as a tool for predicting risk. To evaluate risks, scientists need to do more research. Research in this area is leading toward individualized care more. Now ways for determining and predicting health risks for developing adverse cardiovascular outcomes are enhanced.